Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy

Gynecologic Oncology

Volumn 84, Issue 2, 2002, Pages 289-295

  Nakamoto, Yuji ^a   Eisbruch, Avraham ^b   Achtyes, Eric D ^b   Sugawara, Yoshifumi ^c   Reynolds, Kevin R ^b   Johnston, Carolyn M ^b   Wahl, Richard L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c EHIME UNIVERSITY   (Japan)

Author keywords

FDG; PET; Recurrence; Uterine cervical cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CALCULATION; CANCER CONTROL; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LEAN BODY WEIGHT; PATHOLOGICAL ANATOMY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIOISOTOPE DISTRIBUTION; SCORING SYSTEM; UTERINE CERVIX CANCER;

EID: 0036172542     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6504     Document Type: Article

References (26)

1. Surgical management of advanced and recurrent cervical cancer
2. Recurrent cancer of the cervix following radical hysterectomy and pelvic node dissection
3. Radiotherapy for centrally recurrent cervical cancer of the vaginal stump following hysterectomy
4. Dynamic MR imaging of recurrent postoperative cervical cancer
5. Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: Value of dynamic contrast-enhanced subtraction MR imaging
6. Recurrence of colorectal tumors: PET evaluation
7. Staging recurrent metastatic colorectal carcinoma with PET
8. Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer
9. Evaluation of FDG PET in patients with cervical cancer
10. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: A surgicopathologic study
11. Early diagnosis and evaluation of therapy in postoperative recurrent cervical cancers by positron emission tomography
12. 18F-FDG-PET) in the diagnosis of recurrence and lymph node metastasis of cervical cancer
13. Radiation alternating with bromodeoxyuridine for advanced uterine cervix cancer: A phase I and drug incorporation study
14. 18F]fluoro-D-glucose by direct nucleophilic exchange on a quatenary 4-aminopyridinium resin
15. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: Variations with body weight and a method for correction
16. A new approach for testing the significance of differences between ROC curves measured from correlated data
17. Persistent or recurrent bronchogenic carcinoma: Detection with PET and 2-[F-18]-2-deoxy-D-glucose
18. Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnostics of oncological patients
19. In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy
20. FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms
21. Positron emission tomography: An independent indicator of radiocurability in head and neck carcinomas
22. Recurrence of head and neck cancer after surgery or irradiation: Prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses
23. Recurrent cervical carcinoma: Typical and atypical manifestations
24. Clinical evaluation of serum and immunohistochemical expression of SCC and CA 19-9 in radiation therapy for Cervical cancer
25. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix
26. Serum CYFRA 21-1 in cervical cancer patients treated with radiation therapy